ARCHIVES

Also in this 8-page issue: FDA begins search for director of new Office of Oncology Drug Products.

This article is from The Cancer Letter archive.

Vol. 30 No. 38 | October 8, 2004

Download PDF Visit The Full Archive

Related Articles

Interferon “Hysteria” Prompts ASCO To Warn Against Expecting Immediate Benefits

June 20, 1980

NCI Launches Effort In Cancer Education For Older Americans; Also An ACS Goal, Dodd Tells Writers

March 29, 1991

ACS Encourages Research Proposals Psychosocial Aspects Of Cancer

March 26, 1982

Two-Point Rise In PSA Signals High-Risk Prostate Cancer

August 26, 2005

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001

Funding opportunities listed.

April 30, 2004